The United States of America; as represented by The Secretary; Department of Health and Human Services
发明人:
Wainer, Irving W.,Bernier, Michel,Paul, Rajib K.
申请号：
AU2013266235
公开号：
AU2013266235A1
申请日:
2013.05.23
申请国别(地区):
AU
年份:
2014
代理人:
摘要：
This disclosure concerns the discovery of the use of fenoterol analogues for regulating cannabinoid (CB) receptor activity-related disorders and disease, such as dysregulated CB receptors, including treating a disorder or disease, such as a glioblastoma, hepatocellular carcinoma, liver cancer, colon cancer, and/or lung cancer, which is associated with altered cannabinoid receptor activity. In one example, the method includes administering to a subject having or at risk of developing a disorder or disease regulated by CB receptor activity an effective amount of a fenoterol analogue to reduce one or more symptoms associated with the disorder or disease regulated by CB receptor activity.
